Literature DB >> 17617524

Management of borderline ovarian neoplasms.

Isabelle Cadron1, Karin Leunen, Toon Van Gorp, Frederic Amant, Patrick Neven, Ignace Vergote.   

Abstract

Over the last decades, the management of borderline ovarian tumors (BOTs) has changed from radical surgery to more conservative therapy as a result of the need for fertility-sparing surgery and the increasing use of laparoscopy. The question is whether this is good clinical practice from an oncologic point of view. Here, recent literature regarding management of borderline ovarian neoplasms is reviewed, and oncologic concerns are discussed with emphasis on the mode of surgery and the possibility of fertility-sparing surgery and its consequences. Proper staging is defined as an exploration of the entire abdominal cavity with peritoneal washings, infracolic omentectomy, and multiple peritoneal biopsies as the cornerstone of a successful treatment, and this is only possible through a midline incision. For stage I disease, conservative surgery consisting of unilateral salpingo-oophorectomy or cystectomy in case of bilateral ovarian involvement or when the disease develops in the only remaining ovary is a valuable alternative in a number of young patients who want to preserve their fertility. Patients with advanced-stage disease or who are finished childbearing are treated with radical surgery consisting of peritoneal washings, total abdominal hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, complete peritoneal resection of macroscopic lesions, or multiple peritoneal biopsies; in case of mucinous BOTs, patients also are treated with an appendectomy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617524     DOI: 10.1200/JCO.2007.10.8076

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  33 in total

1.  Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.

Authors:  Kevin M Elias; S Intidhar Labidi-Galy; Allison F Vitonis; Jason L Hornick; Leona A Doyle; Michelle S Hirsch; Daniel W Cramer; Ronny Drapkin
Journal:  Gynecol Oncol       Date:  2013-12-14       Impact factor: 5.482

Review 2.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

3.  Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT.

Authors:  Chulhan Kim; Hyun Hoon Chung; So Won Oh; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-04-04

Review 4.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

Review 5.  [Intraoperative frozen sections in diseases of the female genital tract].

Authors:  S Lax; K Tamussino; K Prein; P Lang
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

Review 6.  Interventions for the treatment of borderline ovarian tumours.

Authors:  Olusola Faluyi; Melanie Mackean; Charlie Gourley; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

7.  Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.

Authors:  Karin K Shih; Qin C Zhou; Carol Aghajanian; Jae Huh; Robert A Soslow; Jessica C Morgan; Alexia Iasonos; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2010-08-16       Impact factor: 5.482

Review 8.  Role of ultrasound in the detection of recurrent ovarian cancer: a review of the literature.

Authors:  Andrea Rosati; Salvatore Gueli Alletti; Vito Andrea Capozzi; Mariateresa Mirandola; Virginia Vargiu; Camilla Fedele; Stefano Uccella; Carmine Vascone
Journal:  Gland Surg       Date:  2020-08

Review 9.  Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.

Authors:  S Avril
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

10.  Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary.

Authors:  Jin Hwi Kim; Tae Jung Kim; Yong Gyu Park; Sung Ha Lee; Chung Won Lee; Min Jong Song; Keun Ho Lee; Soo Young Hur; Seog Nyeon Bae; Jong Sup Park
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.